New treatment directions for patients with myeloma

Published on

Email this program

Get Link

At the 20th Congress of the European Hematology Association (EHA), Dr Pieter Sonneveld, of the Erasmus MC University Cancer Institute, Rotterdam, the Netherlands, considers some of the opportunities and challenges of emerging approaches, which are in active clinical trials, that are aiming to improve treatment outcomes in patients with myeloma. Supportive care is highlighted as an area of importance.

View more programs featuring


Page last updated on January 26, 2016